biotech | KUOW News and Information

biotech

New biometric technology will match your face with your passport photo at airport customs. Is this a cause for celebration or concern?
Flickr Photo/Kat (CC BY 2.0)/flic.kr/p/6gTcVm

Assumptions about which passport line you belong in, the president's so-called Muslim ban, "random" screening that seems to target certain populations - airports are increasingly a frontier of ethnic and religious bias. Could we bypass some of those problems by taking the human element out of screening?

Facial recognition software has the potential to transform our surveillance ability: for better or for worse.
Flickr Photo/Sam Cox (CC BY 2.0)/flic.kr/p/S7S39Y

So you're walking down the street - probably not making eye contact with anyone, if you're from Seattle. But with Amazon's help, even if you're not looking at anyone, law enforcement might be looking at you.


The DNA molecule is elegant, personal, and can give away a lot more secrets than it lets on.
Flickr Photo/Michał Kosmulski (CC BY 2.0)/https://flic.kr/p/BTfEMJ

The Golden State Killer’s arrest last week brought closure to victims and community members affected by a ten year spree of rapes and murder. The trail went cold in 1986, and it stayed that way until the FBI made a fake profile for the killer on a genealogy website. They used this to trace 500 partial matches, screen for 100 potential matches, and eventually narrow down to former police officer Joseph DeAngelo.

For years, the government has been trying to reduce the risk that legitimate biological research could be misused to threaten the public's health, but those efforts have serious shortcomings.

That's the conclusion of a report released Thursday by the prestigious National Academies of Sciences, Engineering, and Medicine that examined existing practices and policies on so-called dual-use biological research.

Bill Radke talks to Jon Talton, Seattle Times economics columnist, about what it would mean for the Northwest if the proposed cuts to the National Institutes of Health funding were enacted.

Biomedical research is going big-time: Megaprojects that collect vast stores of data are proliferating rapidly. But scientists' ability to make sense of all that information isn't keeping up.

This conundrum took center stage at a meeting of patient advocates, called Partnering For Cures, in New York City on Nov. 15.

On the one hand, there's an embarrassment of riches, as billions of dollars are spent on these megaprojects.

Bill Radke talks to biotech journalist Luke Timmerman about his new book, "Hood: Trailblazer of the Genomics Age." 

Bill Radke speaks with Luke Timmerman about what went wrong during Seattle-based Juno Therapeutics' clinical trial of an immunotherapy treatment for leukemia and what it might mean for the company.

Jeannie Yandel talks to Luke Timmerman of the Timmerman Report about Chris Rivera's tenure as President of the Washington Biotechnology And Biomedical Association. 

Marcie Sillman talks to Luke Timmerman, founder and editor of the Timmerman Report, about Juno Therapeutics and other biotech startups like Just Biotherapeutics that came out of the closure of Amgen's Seattle offices last year. 

The Fred Hutchison Cancer Research Center as seen from Lake Union.
Flickr Photo/sea turtle (CC-BY-NC-ND)

Marcie Sillman talks to Luke Timmerman, of the Timmerman Report, about the Fred Hutchinson's Cancer Research Center's efforts to find new ways to bring in revenue for research. 

biotech file photo
Flickr Photo/HCC PIO (CC BY-NC-ND 2.0)

Marcie Sillman talks to Luke Timmerman about the growth of a Seattle biotech company, Adaptive Biotechnologies, and what it means for the city's biotechnology industry.

Ross Reynolds talks to Seattle biotech writer Luke Timmerman about the biotech company Dendreon, which filed for bankruptcy after their prostate cancer drug failed to make a sizable profit.

Marcie Sillman talks to biotech writer Luke Timmerman about the influx of money to cancer immunotherapy companies like VentriRx, which just received $50 million to increase their research efforts.

Ross Reynolds talks to biotech reporter, Luke Timmerman, about what types of treatments biologist are studying for Ebola.

Flickr Photo/Thomas Hawk (Cc-BY-NC-ND)

Jeannie Yandel talks to Jon Talton, economic columnist for the Seattle Times and writer for the blog Rogue Columnist, about the Puget Sound's economic climate.

T-Mobile is for sale two companies, Spring and the French company, Illiad, are interested in buying it.

Also, what is the biggest danger to the Northwest's economy?

Amgen is moving out, and Expedia is moving into Seattle.
Flickr Photo/Chas Redmond (CC-BY-NC-ND)

California-based biotech firm Amgen announced on Tuesday that it would close its Seattle and Bothell campuses by 2015, resulting in the loss of 660 jobs locally. The closure is part of a company-wide layoff of an estimated 2,400 to 2,900.

Marcie Sillman talks to biotech journalist Luke Timmerman about the pharmaceutical company Merck buying the biotech company Idenix for  over $3 billion and what that means for the future of a hepatitis C treatment. Also, they discuss the latest from the American Society Of Clinical Oncology meeting.

Flickr Photo/Adam Brandejs

How is biotechnology changing our pets, our livestock and other wild things? Ross Reynolds talks with Emily Anthes, the author of "Frankenstein’s Cat: Cuddling up to Biotech’s Brave New Beasts," about how biotech will change our pets and livestock.

This interview originally aired on March 14, 2013.

Flickr Photo/World Bank Photo Collection

The biotech industry took a big hit during the recession, and it can still be difficult in this area to find and keep work in that field. But for those looking to enter the industry there are a few things you should keep in mind. Luke Timmerman, the national biotech editor at Xconomy, an online business and technology blog, explains what you should consider before taking a job in biotech and the challenges of the industry.

Biotech News, And What's In The Fridge?

Aug 2, 2013
KUOW Photo/Carmen Santos

Biotech News
What's happening in the world of biotech? Journalist Luke Timmerman from Xconomy tells us about the region’s big stories.

What’s In The Fridge?
“The Chef in the Hat” Thierry Rautureau joins us to make new recipes from the leftovers in your fridge. Have a look inside and tell us what ingredients you have. We'll help you make a delicious dinner without a trip to the store. Call us at 800.289.5869 or email Weekday.  

Weekend Weather Forecast
State climatologist Nick Bond gives us a weather forecast for the weekend.